Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urine
- 2 June 1993
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 615 (2) , 309-315
- https://doi.org/10.1016/0378-4347(93)80346-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodentsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxinsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Keynote address: Bioreductive mechanismsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicityBritish Journal of Cancer, 1992
- Gradient high-performance liquid chromatographic assay for the determination of the novel indoloquinone antitumour agent E09 in biological specimensJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Mitomycin analogs I. Indoloquinones as (potential) bisalkylating agentsTetrahedron, 1987